Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/27874
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18074/20272 (89%)
Visitors : 2464890      Online Users : 953
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/27874


    Title: Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-kappa B-dependent pathway
    Authors: Cheng, Chi-Chih
    Hsueh, Chi-Mei
    Chen, Chiu-Yuan
    Chen, Tzu-Hsiu
    Hsu, Shih-Lan
    Contributors: 保健營養系
    醫藥化學系
    Keywords: Paraoxonase 1
    Interleukin-6
    Akt
    Nf-Kappa B
    Atherosclerosis
    Date: 2013-01
    Issue Date: 2014-05-26 10:47:11 (UTC+8)
    Publisher: Academic Press Inc Elsevier Science
    Abstract: The aim of this study is to investigate the relationship between paraoxonase 1 (PON1) and atherosclerosis-related inflammation. In this study, human hepatoma HepG2 cell line was used as a hepatocyte model to examine the effects of the pro-inflammatory cytokines on PON1 expression. The results showed that IL-6, but not TNF-alpha and IL-1 beta, significantly increased both the function and protein level of PON1; data from real-time RT-PCR analysis revealed that the IL-6-induced PON1 expression occurred at the transcriptional level. Increase of I kappa B kinase activity and I kappa B phosphorylation, and reduction of I kappa B protein level were also observed in IL-6-treated HepG2 cells compared with untreated culture. This event was accompanied by increase of NF-kappa B-p50 and -p65 nuclear translocation. Moreover, treatment with IL-6 augmented the DNA binding activity of NF-kappa B. Furthermore, pharmacological inhibition of NF-kappa B activation by PDTC and BAY 11-7082, markedly suppressed the IL-6-mediated PON1 expression. In addition, IL-6 increased the levels of phosphorylated protein kinase B (PKB, AKT). An AKT inhibitor LY294002 effectively suppressed IKK/I kappa B/NF-kappa B signaling and PON1 gene expression induced by IL-6. Our findings demonstrate that IL-6 upregulates PON1 gene expression through an AKT/NF-kappa B signaling axis in human hepatocyte-derived HepG2 cell line. (c) 2013 Elsevier Inc. All rights reserved.
    Relation: Biochemical And Biophysical Research Communications, v.437 n.1, pp.55-61
    Appears in Collections:[Dept. of Health and Nutrition (including master's program)] Periodical Articles
    [Dept. of Food & Drug Industry and Inspective Technology] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML1644View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback